pubmed-article:20451506 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20451506 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
pubmed-article:20451506 | lifeskim:mentions | umls-concept:C0022116 | lld:lifeskim |
pubmed-article:20451506 | lifeskim:mentions | umls-concept:C0205234 | lld:lifeskim |
pubmed-article:20451506 | lifeskim:mentions | umls-concept:C0598958 | lld:lifeskim |
pubmed-article:20451506 | lifeskim:mentions | umls-concept:C0243076 | lld:lifeskim |
pubmed-article:20451506 | lifeskim:mentions | umls-concept:C1999230 | lld:lifeskim |
pubmed-article:20451506 | lifeskim:mentions | umls-concept:C0205374 | lld:lifeskim |
pubmed-article:20451506 | pubmed:dateCreated | 2010-7-8 | lld:pubmed |
pubmed-article:20451506 | pubmed:abstractText | We have reported the neuroprotective effects of pre-treatment with beta-adrenoceptor antagonists on the cerebral infarction at 1 and 7 days after focal ischemia in rats. However, the protective effect of post-treatment with beta-adrenoceptor antagonists has not been investigated yet. This study was conducted to evaluate the post-treatment effects of selective beta(1)-adrenoceptor antagonists in the rat focal cerebral ischemia. Halothane anesthetized, normothermic adult male Sprague-Dawley rats were subjected to 2h of middle cerebral artery occlusion (MCAO) using the intraluminal suture technique confirmed by laser Doppler flowmetry. Rats received intravenous infusion of saline 0.5 mL/h, esmolol 200 microg/kg/min, or landiolol 50 microg/kg/min (n=8 in each group). Infusion was initiated 30 min after MCAO and continued for 24h. Rats were allowed to survive for 7 days, and the neurological deficit score was evaluated at 1, 4 and 7 days after reperfusion. The brains were removed and stained with triphenyltetrazolium chloride at 7 days after reperfusion. Neurological deficit scores were lower in the rats treated with esmolol or landiolol, compared with saline-treated rats at 1 day as well as 4 and 7 days. The infarct volumes of cortical and striatum were less in the rats receiving beta-adrenoceptor antagonists than in saline-treated rats (P<0.05). The current study indicates that administration of selective beta1-adrenoceptor antagonists after the onset of ischemia also improved neurological and histological outcomes following transient focal cerebral ischemia in rats. | lld:pubmed |
pubmed-article:20451506 | pubmed:language | eng | lld:pubmed |
pubmed-article:20451506 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20451506 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20451506 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20451506 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20451506 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20451506 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20451506 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20451506 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20451506 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20451506 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20451506 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20451506 | pubmed:month | Jul | lld:pubmed |
pubmed-article:20451506 | pubmed:issn | 1872-6240 | lld:pubmed |
pubmed-article:20451506 | pubmed:author | pubmed-author:HoriguchiTaka... | lld:pubmed |
pubmed-article:20451506 | pubmed:author | pubmed-author:GoyagiToruT | lld:pubmed |
pubmed-article:20451506 | pubmed:author | pubmed-author:NishikawaTosh... | lld:pubmed |
pubmed-article:20451506 | pubmed:author | pubmed-author:TobeYoshitsug... | lld:pubmed |
pubmed-article:20451506 | pubmed:copyrightInfo | Copyright (c) 2010 Elsevier B.V. All rights reserved. | lld:pubmed |
pubmed-article:20451506 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20451506 | pubmed:day | 9 | lld:pubmed |
pubmed-article:20451506 | pubmed:volume | 1343 | lld:pubmed |
pubmed-article:20451506 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20451506 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20451506 | pubmed:pagination | 213-7 | lld:pubmed |
pubmed-article:20451506 | pubmed:meshHeading | pubmed-meshheading:20451506... | lld:pubmed |
pubmed-article:20451506 | pubmed:meshHeading | pubmed-meshheading:20451506... | lld:pubmed |
pubmed-article:20451506 | pubmed:meshHeading | pubmed-meshheading:20451506... | lld:pubmed |
pubmed-article:20451506 | pubmed:meshHeading | pubmed-meshheading:20451506... | lld:pubmed |
pubmed-article:20451506 | pubmed:meshHeading | pubmed-meshheading:20451506... | lld:pubmed |
pubmed-article:20451506 | pubmed:meshHeading | pubmed-meshheading:20451506... | lld:pubmed |
pubmed-article:20451506 | pubmed:meshHeading | pubmed-meshheading:20451506... | lld:pubmed |
pubmed-article:20451506 | pubmed:meshHeading | pubmed-meshheading:20451506... | lld:pubmed |
pubmed-article:20451506 | pubmed:meshHeading | pubmed-meshheading:20451506... | lld:pubmed |
pubmed-article:20451506 | pubmed:meshHeading | pubmed-meshheading:20451506... | lld:pubmed |
pubmed-article:20451506 | pubmed:meshHeading | pubmed-meshheading:20451506... | lld:pubmed |
pubmed-article:20451506 | pubmed:meshHeading | pubmed-meshheading:20451506... | lld:pubmed |
pubmed-article:20451506 | pubmed:meshHeading | pubmed-meshheading:20451506... | lld:pubmed |
pubmed-article:20451506 | pubmed:meshHeading | pubmed-meshheading:20451506... | lld:pubmed |
pubmed-article:20451506 | pubmed:meshHeading | pubmed-meshheading:20451506... | lld:pubmed |
pubmed-article:20451506 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20451506 | pubmed:articleTitle | Post-treatment with selective ?1 adrenoceptor antagonists provides neuroprotection against transient focal ischemia in rats. | lld:pubmed |
pubmed-article:20451506 | pubmed:affiliation | Department of Anesthesia and Intensive Care Medicine, Akita University Graduate School of Medicine, Akita, Japan. tgoyagi@doc.med.akita-u.ac.jp | lld:pubmed |
pubmed-article:20451506 | pubmed:publicationType | Journal Article | lld:pubmed |
entrez-gene:24925 | entrezgene:pubmed | pubmed-article:20451506 | lld:entrezgene |